Reply
1. CAS 565456-77-1 Intermediate
2. CAS 328086-60-8 Intermediate
3. CAS 62965-35-9 Intermediate
4. CAS 148893-10-1 Intermediate
info@aeqpharma.com
contact us for get our best offer.
info@aeqpharma.com
hostrinlifesciences@gmail.com
Dear Friends,
Greetings from Hostrin Life sciences!!!
Greetings from CRISTONE LIFE CARE !!!
We have been supporting the following services.
1.We do support DMF for API, Tech transfer support,Compilation/Registration of Dossiers in MOH /MHRA/EMEA/USA support in CTD, ACTD, eCTD and ANDA's formats with 5 modules including BA and BE studies /Clinical studies/trials for API & Formulations in Pharmaceutical, Ayurveda, Biotech, Biosimilar, vitamins , Peptides and recently Transdermal patches too.
2. Impurities & Reference standards support for API's
3. Services for IPR & Regulatory compliance
4. Services for QMS & supporting of QBD - SIGMA TECH Software version 3.1 for DOE, Robustness for the R&D in Pharma, Biotech, Biosimilars companies who are willing to enter into the Regulatory market which is mandatory to show for FDA.
5. Custom synthesis & Contract manufacturing services
6. Synthetic Resins technologies support
Pls don't hesitate to send your inquiry. For your reference please go through our website www.hostringlobal.com.
7. We have been exporting various finished formulations, API's, Biotech & Biosimilar products from CRISTONE LIFE CARE, please visit our website: www.cristoneglobal.com for supply.
Please send your enquiries to cristonelifecare@gmail.com.
Best Regards,
Andrew P
CEO & Managing Director
Hostrin Life sciences
hostrinlifesciences@gmail.com/andrew@hostringlobal.com
Mobile/WhatsApp: +91 9949930343
bd4@nivaara.com
Nivaara is a CRAMS company offering Advance Intermediates & Key Starting materials for NCE (New Chemical Entity) molecules. We help R&D Centers and API Mfg in their quest of developing new APIs by providing them with the required Building blocks, Advance Intermediate and KSMs from grams scale to commercial quantity. We offer the complete documentation support required for regulatory purposes.
We are currently offering intermediates of Edoxoban, Rivaroxaban, Dapaglflozin, Bempadoic acid, Brivaracetam, Olmesartan, Cabetogravir, Voxelator and Pretomanid.
We request you to kindly let us know your requirements on new product development requirements to my email id bd4@nivaara.com.
Thanking you in Advance.
Regards,
Sanjay Gupta,
9967793247
